Deborah A. Springell
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Response-adapted chimeric antigen receptor T cell (CAR-T)-sparing consolidation radiotherapy in high-risk large B-cell lymphoma (LBCL): Results of the prospective RESTART protocol.
Journal: British journal of haematology
Published: April 06, 2026
Outcome and feasibility of radiotherapy bridging in large B-cell lymphoma patients receiving CD19 CAR T in the UK.
Journal: British journal of haematology
Published: February 06, 2024
Improved outcomes of large B-cell lymphoma patients treated with CD19 CAR T in the UK over time.
Journal: British journal of haematology
Published: July 08, 2023
Supportive care for chimeric antigen receptor T-cell patients.
Journal: Current opinion in supportive and palliative care
Published: July 07, 2023
High pretreatment disease burden as a risk factor for infectious complications following CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma.
Journal: HemaSphere
Published: June 29, 2023
Mucormycosis after CD19 chimeric antigen receptor T-cell therapy: results of a US Food and Drug Administration adverse events reporting system analysis and a review of the literature.
Journal: The Lancet. Infectious diseases
Published: February 07, 2023
Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine: Comment from Doyle et al.
Journal: Journal of thrombosis and haemostasis : JTH
Published: December 14, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026